They reported that PDX samples preserved most of the genetic driver alterations in the original tumor samples and could even capture common and rare mutations of TERT, EGFR, PTEN, TP53, BRAF, and IDH1 comparable with glioblastoma tissue samples. This evidence concerns the gene BRAF and neoplasm.